Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Agency: National Institutes of Health
- 93.395 -- Cancer Treatment Research
- 93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
- 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
- 93.393 -- Cancer Cause and Prevention Research
- 93.361 -- Nursing Research
- 93.173 -- Research Related to Deafness and Communication Disorders
- 93.396 -- Cancer Biology Research
- 93.399 -- Cancer Control
- 93.867 -- Vision Research
- 93.273 -- Alcohol Research Programs
- 93.837 -- Cardiovascular Diseases Research
- 93.838 -- Lung Diseases Research
- 93.394 -- Cancer Detection and Diagnosis Research
- 93.242 -- Mental Health Research Grants
- 93.866 -- Aging Research
- 93.865 -- Child Health and Human Development Extramural Research
- 93.279 -- Drug Abuse and Addiction Research Programs
- 93.839 -- Blood Diseases and Resources Research
- 93.233 -- National Center on Sleep Disorders Research
Open opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions.Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole.This Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For the purpose of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.
Eligibility
Eligible applicants
Education
- Public and state institutions of higher education
- Private institutions of higher education
Miscellaneous
- Other
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
| File name | Description | Last updated |
|---|---|---|
| PAR-24-214-Full-Announcement.html | PAR-24-214 Full Announcement Text | May 8, 2024 01:20 PM UTC |
Link to additional information
https://grants.nih.gov/grants/guide/pa-files/PAR-24-214.html
Closing: January 7, 2027
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$375,000
Award Maximum
Funding opportunity number:
PAR-24-214
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Education
Health
Income security and social services
Category Explanation:
History
Version:
2
Posted date:
May 8, 2024
Archive date:
February 6, 2027
